A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing-Reference-Cited by-同舟云学术

A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing

Published:2006-09 Issue:15 Volume:312 Page:2726-2734
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Ke Ning,Zhou Demin,E. Chatterton Jon,Liu Guohong,Chionis John,Zhang Jing,Tsugawa Lindsey,Lynn Rebecca,Yu Dehua,Meyhack Bernd,Wong-Staal Flossie,Li Qi-Xiang

Publisher

Elsevier BV

Subject

Cell Biology

Reference34 articles.

1. Mouse models in cancer drug discovery and development;Sausville,2004

2. What's wrong with our cancer models?;Kamb;Nat. Rev., Drug Discov.,2005

3. Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil;Wang;Cancer Res.,2004

4. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo;Li;Cancer Res.,2005

5. Development of a tightly regulated U6 promoter for shRNA expression;Lin;FEBS Lett.,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of mTOR Expression by siRNA Leads to Cell Cycle Arrest and Apoptosis Induction in MDA-MB-231 Breast Cancer Cells;Current Gene Therapy;2023-06

2. In Vivo Pharmacology Models for Cancer Target Research;Target Identification and Validation in Drug Discovery;2019

3. Doxycycline inhibits proliferation and induces apoptosis of both human papillomavirus positive and negative cervical cancer cell lines;Canadian Journal of Physiology and Pharmacology;2016-05

4. HMGB1: A Promising Therapeutic Target for Prostate Cancer;Prostate Cancer;2013

5. In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence;Journal of Hepatology;2010-05